首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1489228

全球灌裝藥品合約製造市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Fill-finish Pharmaceutical Contract Manufacturing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 168 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球灌裝藥品合約製造市場的需求預計將從 2023 年的 83.6 億美元達到 2032 年近 155.1 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.11%。

灌裝完成製藥合約製造涉及生產藥品的最後步驟，其中將散裝原料藥填充到容器（西林瓶、注射器、安瓿）中，然後密封。過程包括滅菌、填充、封蓋、貼標籤和包裝，確保產品安全、無菌並可供分銷。合約製造商向製藥公司提供這些服務，幫助他們擴大生產規模、滿足監管標準並縮短上市時間。這項服務對於需要無菌處理的生物製品、疫苗和注射藥物至關重要。

市場動態

生物製藥產品（包括生物製品、疫苗和細胞療法）的不斷成長推動了對灌裝藥品合約製造的需求。製藥業日益全球化以及對靈活製造解決方案的需求推動了對灌裝-完成合約製造服務的需求。這些服務使製藥公司能夠在全球範圍內獲得製造能力和專業知識，從而降低供應鏈風險並加快產品開發時間。藥品生產和包裝的嚴格監管要求凸顯了與符合現行良好生產規範 (cGMP) 和其他監管標準、經驗豐富的灌裝藥品合約製造商合作的重要性。

此外，外包非核心製造活動和專注於核心能力的趨勢不斷成長，這激勵製藥公司聘請灌裝完成CMO來滿足其製造需求，最佳化資源分配和營運效率。然而，監管障礙和內部製造的競爭可能會在未來幾年挑戰灌裝藥品合約製造市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球灌裝製藥合約製造市場的每個細分市場進行了包容性評估。灌裝製藥合約製造業的成長和趨勢為本研究提供了整體方法。

市場區隔

灌裝完成藥品合約製造市場報告的這一部分提供了國家和區域層面的細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

西林瓶（玻璃西林瓶、塑膠西林瓶）
預充式注射器 (PFS)（玻璃 PFS、塑膠 PFS）
墨水匣
其他產品

按分子

大分子
小分子

按最終用途

生物製藥公司
製藥公司

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的灌裝藥品合約製造市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。填充完成藥品合約製造市場的主要參與者包括 Boehringer Ingelheim International GmbH、Catalent Inc.、Eurofins Scientific、Fresenius Kabi Contract Manufacturing、MabPlex International Co. Ltd.、Novartis AG、Recipharm AB、Societal CDMO、Simtra BioPharma Solutions（百特國際公司）、共生製藥服務公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：灌裝製藥合約製造公司的競爭格局

灌裝完成藥品合約製造市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Boehringer Ingelheim International GmbH

公司簡介
公司收入
產品
最近的發展

Catalent Inc.

公司簡介
公司收入
產品
最近的發展

Eurofins Scientific

公司簡介
公司收入
產品
最近的發展

Fresenius Kabi Contract Manufacturing

公司簡介
公司收入
產品
最近的發展

MabPlex International Co. Ltd.

公司簡介
公司收入
產品
最近的發展

Novartis AG

公司簡介
公司收入
產品
最近的發展

Recipharm AB

公司簡介
公司收入
產品
最近的發展

Societal CDMO

公司簡介
公司收入
產品
最近的發展

Simtra BioPharma Solutions (Baxter International Inc.)

公司簡介
公司收入
產品
最近的發展

Symbiosis Pharmaceutical Services

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114625

The global demand for Fill-finish Pharmaceutical Contract Manufacturing Market is presumed to reach the market size of nearly USD 15.51 Billion by 2032 from USD 8.36 Billion in 2023 with a CAGR of 7.11% under the study period 2024-2032.

Fill-finish pharmaceutical contract manufacturing involves the final steps in producing pharmaceutical products, where bulk drug substances are filled into containers (vials, syringes, ampoules) and then sealed. This process includes sterilization, filling, capping, labeling, and packaging, ensuring the product is safe, sterile, and ready for distribution. Contract manufacturers provide these services to pharmaceutical companies, helping them to scale production, meet regulatory standards, and reduce time-to-market. This service is crucial for biologics, vaccines, and injectable drugs requiring aseptic processing.

MARKET DYNAMICS

The growing pipeline of biopharmaceutical products, including biologics, vaccines, and cell therapies, drives the need for fill-finish pharmaceutical contract manufacturing. The increasing globalization of the pharmaceutical industry and the need for flexible manufacturing solutions drive the demand for fill-finish contract manufacturing services. These services enable pharmaceutical companies to access manufacturing capacity and expertise on a global scale, mitigating supply chain risks and accelerating product development timelines. The stringent regulatory requirements governing pharmaceutical manufacturing and packaging underscore the importance of partnering with experienced fill-finish pharmaceutical contract manufacturers that comply with current good manufacturing practices (cGMP) and other regulatory standards.

Furthermore, the growing trend towards outsourcing non-core manufacturing activities and focusing on core competencies incentivizes pharmaceutical companies to engage fill-finish CMOs for their manufacturing needs, optimizing resource allocation and operational efficiency. However, regulatory hurdles and competition from in-house manufacturing may challenge the fill-finish pharmaceutical contract manufacturing market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Fill-finish Pharmaceutical Contract Manufacturing. The growth and trends of Fill-finish Pharmaceutical Contract Manufacturing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Fill-finish Pharmaceutical Contract Manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Vials (Glass Vials, Plastic Vials)
Prefilled Syringes (PFS) (Glass PFS, Plastic PFS)
Cartridges
Other Products

By Molecule

Large Molecules
Small Molecules

By End-Use

Biopharmaceutical Companies
Pharmaceutical Companies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Fill-finish Pharmaceutical Contract Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Fill-finish Pharmaceutical Contract Manufacturing market include Boehringer Ingelheim International GmbH, Catalent Inc., Eurofins Scientific, Fresenius Kabi Contract Manufacturing, MabPlex International Co. Ltd., Novartis AG, Recipharm AB, Societal CDMO, Simtra BioPharma Solutions (Baxter International Inc.), Symbiosis Pharmaceutical Services. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Molecule
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Vials (Glass Vials, Plastic Vials) Historic and Forecast Sales By Regions
5.5. Prefilled Syringes (PFS) (Glass PFS, Plastic PFS) Historic and Forecast Sales By Regions
5.6. Cartridges Historic and Forecast Sales By Regions
5.7. Other Products Historic and Forecast Sales By Regions

6. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY MOLECULE

6.1. Overview By Molecule
6.2. Historical and Forecast Data
6.3. Analysis By Molecule
6.4. Large Molecules Historic and Forecast Sales By Regions
6.5. Small Molecules Historic and Forecast Sales By Regions

7. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY END-USE

7.1. Overview By End-Use
7.2. Historical and Forecast Data
7.3. Analysis By End-Use
7.4. Biopharmaceutical Companies Historic and Forecast Sales By Regions
7.5. Pharmaceutical Companies Historic and Forecast Sales By Regions

8. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING COMPANIES

9.1. Fill-finish Pharmaceutical Contract Manufacturing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boehringer Ingelheim International GmbH
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Catalent Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Eurofins Scientific
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Fresenius Kabi Contract Manufacturing
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. MabPlex International Co. Ltd.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Novartis AG
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Recipharm AB
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Societal CDMO
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Simtra BioPharma Solutions (Baxter International Inc.)
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Symbiosis Pharmaceutical Services
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Vials (Glass Vials, Plastic Vials) Market Sales By Geography (USD MN)
Prefilled Syringes (PFS) (Glass PFS, Plastic PFS) Market Sales By Geography (USD MN)
Cartridges Market Sales By Geography (USD MN)
Other Products Market Sales By Geography (USD MN)
Analysis By Molecule (USD MN)
Large Molecules Market Sales By Geography (USD MN)
Small Molecules Market Sales By Geography (USD MN)
Analysis By End-Use (USD MN)
Biopharmaceutical Companies Market Sales By Geography (USD MN)
Pharmaceutical Companies Market Sales By Geography (USD MN)
Global Fill-finish Pharmaceutical Contract Manufacturing Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Fill-finish Pharmaceutical Contract Manufacturing Report
Market Research Process
Market Research Methodology
Global Fill-finish Pharmaceutical Contract Manufacturing Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Molecule
Market Attractiveness Analysis By End-Use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Vials (Glass Vials, Plastic Vials) Market Sales By Geography (USD MN)
Prefilled Syringes (PFS) (Glass PFS, Plastic PFS) Market Sales By Geography (USD MN)
Cartridges Market Sales By Geography (USD MN)
Other Products Market Sales By Geography (USD MN)
Global Market Analysis By Molecule (USD MN)
Large Molecules Market Sales By Geography (USD MN)
Small Molecules Market Sales By Geography (USD MN)
Global Market Analysis By End-Use (USD MN)
Biopharmaceutical Companies Market Sales By Geography (USD MN)
Pharmaceutical Companies Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis